Lian, Ying, Srivastava, Indresh, Gomez-Roman, V.R., Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...
This article was written by Prof Janse van Rensburg before she joined the University of Pretoria.
Lian, Ying, Srivastava, Indresh, Gomez-Roman, V.R., Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...
This article was written by Prof Janse van Rensburg before she joined the University of Pretoria.
Scriba, Thomas Jens, Zur Megede, Jan, Glashoff, Richard H., Treurnicht, Florette K., Barnett, Susan W., Janse Van Rensburg, Estrelita
The efficacy of cellular immune responses elicited by HIV vaccines is dependent on their strength, durability and antigenic breadth. The regulatory proteins are abundantly expressed early in the...
Scriba, Thomas Jens, Zur Megede, Jan, Glashoff, Richard H., Treurnicht, Florette K., Barnett, Susan W., Janse Van Rensburg, Estrelita
The efficacy of cellular immune responses elicited by HIV vaccines is dependent on their strength, durability and antigenic breadth. The regulatory proteins are abundantly expressed early in the...
De Oliveira, Tulio, Engelbrecht, Susan, Janse Van Rensburg, Estrelita, Gordon, Michelle, Bishop, Karen, Zur Megede, Jan, ...
This article was written by Prof Janse van Rensburg and Prof Cassol before they joined the University of Pretoria.
De Oliveira, Tulio, Engelbrecht, Susan, Janse Van Rensburg, Estrelita, Gordon, Michelle, Bishop, Karen, Zur Megede, Jan, ...
This article was written by Prof Janse van Rensburg and Prof Cassol before they joined the University of Pretoria.
Zur Megede, Jan, Engelbrecht, Susan, De Oliveira, Tulio, Cassol, Sharon, Scriba, Thomas Jens, Janse Van Rensburg, Estrelita, ...
The publisher does not allow open access to the full text of this item. If you however need access to the full text, please contact the Collection Administrator, or access the item via the e-journal...
Zur Megede, Jan, Engelbrecht, Susan, De Oliveira, Tulio, Cassol, Sharon, Scriba, Thomas Jens, Janse Van Rensburg, Estrelita, ...
The publisher does not allow open access to the full text of this item. If you however need access to the full text, please contact the Collection Administrator, or access the item via the e-journal...
Scriba, Thomas Jens, De Villiers, Tania, Treurnicht, Florette K., Zur Megede, Jan, Barnett, Susan W., Engelbrecht, Susan, ...
This article was written by Prof Janse van Rensburg before she joined the University of Pretoria.
Scriba, Thomas Jens, De Villiers, Tania, Treurnicht, Florette K., Zur Megede, Jan, Barnett, Susan W., Engelbrecht, Susan, ...
This article was written by Prof Janse van Rensburg before she joined the University of Pretoria.
Engelbrecht, Susan, De Villiers, Tania, Sampson, Candice C., Zur Megede, Jan, Barnett, Susan W., Janse Van Rensburg, Estrelita
The publisher does not allow open access to the full text of this sequence note. If you however need access to the full text, please contact the Collection Administrator, or access the item via the...
Engelbrecht, Susan, De Villiers, Tania, Sampson, Candice C., Zur Megede, Jan, Barnett, Susan W., Janse Van Rensburg, Estrelita
The publisher does not allow open access to the full text of this sequence note. If you however need access to the full text, please contact the Collection Administrator, or access the item via the...
Beer, Brigitte, Baier, Michael, Zur Megede, Jan, Norley, Stephen, Kurth, Reinhard
Immunization of adult macaques with live attenuated simian immunodeficiency viruses (SIVs) lacking the nef genes has been shown to protect against challenge with full-length pathogenic SIV. To test...
Zur Megede, Jan, Chen, Min-Chao, Doe, Barbara, Schaefer, Mary, Greer, Catherine E., Selby, Mark, ...
A major challenge for the next generation of human immunodeficiency virus (HIV) vaccines is the induction of potent, broad, and durable cellular immune responses. The structural protein Gag is highly...
Gardner, Jason P., Frolov, Ilya, Perri, Silvia, Ji, Yaying, MacKichan, Mary Lee, Zur Megede, Jan, ...
The ability to target antigen-presenting cells with vectors encoding desired antigens holds the promise of potent prophylactic and therapeutic vaccines for infectious diseases and cancer. Toward this...
Otten, Gillis, Schaefer, Mary, Greer, Catherine, Calderon-Cacia, Maria, Coit, Doris, Kazzaz, Jina, ...
Several vaccine technologies were evaluated for their abilities to induce anti-human immunodeficiency virus Gag immune responses in rhesus macaques. While no vaccine alone was able to induce broad...
De Oliveira, Tulio, Engelbrecht, Susan, Janse Van Rensburg, Estrelita, Gordon, Michelle, Bishop, Karen, Zur Megede, Jan, ...
Naturally occurring polymorphisms in the protease of human immunodeficiency virus type 1 (HIV-1) subtype C would be expected to lead to adaptive (compensatory) changes in protease cleavage sites. To...
Otten, Gillis R., Schaefer, Mary, Doe, Barbara, Liu, Hong, Srivastava, Indresh, Zur Megede, Jan, ...
DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for...
Lian, Ying, Srivastava, Indresh, Gómez-Román, V. Rául, Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...
Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly...
Zur Megede, Jan, Otten, Gillis R., Doe, Barbara, Liu, Hong, Leung, Louisa, Ulmer, Jeffrey B., ...
Control of the worldwide AIDS pandemic may require not only preventive but also therapeutic immunization strategies. To meet this challenge, the next generation of human immunodeficiency virus type 1...
Beer, Brigitte, Baier, Michael, Zur Megede, Jan, Norley, Stephen, Kurth, Reinhard
Immunization of adult macaques with live attenuated simian immunodeficiency viruses (SIVs) lacking the nef genes has been shown to protect against challenge with full-length pathogenic SIV. To test...
Zur Megede, Jan, Chen, Min-Chao, Doe, Barbara, Schaefer, Mary, Greer, Catherine E., Selby, Mark, ...
A major challenge for the next generation of human immunodeficiency virus (HIV) vaccines is the induction of potent, broad, and durable cellular immune responses. The structural protein Gag is highly...
Gardner, Jason P., Frolov, Ilya, Perri, Silvia, Ji, Yaying, MacKichan, Mary Lee, Zur Megede, Jan, ...
The ability to target antigen-presenting cells with vectors encoding desired antigens holds the promise of potent prophylactic and therapeutic vaccines for infectious diseases and cancer. Toward this...
Otten, Gillis, Schaefer, Mary, Greer, Catherine, Calderon-Cacia, Maria, Coit, Doris, Kazzaz, Jina, ...
Several vaccine technologies were evaluated for their abilities to induce anti-human immunodeficiency virus Gag immune responses in rhesus macaques. While no vaccine alone was able to induce broad...
Zur Megede, Jan, Otten, Gillis R., Doe, Barbara, Liu, Hong, Leung, Louisa, Ulmer, Jeffrey B., ...
Control of the worldwide AIDS pandemic may require not only preventive but also therapeutic immunization strategies. To meet this challenge, the next generation of human immunodeficiency virus type 1...
De Oliveira, Tulio, Engelbrecht, Susan, Janse Van Rensburg, Estrelita, Gordon, Michelle, Bishop, Karen, Zur Megede, Jan, ...
Naturally occurring polymorphisms in the protease of human immunodeficiency virus type 1 (HIV-1) subtype C would be expected to lead to adaptive (compensatory) changes in protease cleavage sites. To...
Otten, Gillis R., Schaefer, Mary, Doe, Barbara, Liu, Hong, Srivastava, Indresh, Zur Megede, Jan, ...
DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for...
Lian, Ying, Srivastava, Indresh, Gómez-Román, V. Rául, Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...
Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly...